Companies are evolving from static reports to living models by strengthening their data backbone with advanced analytics and ...
Final Bria-IMT™ Phase 2 data show 55% >1 year and 27% >2-year survival in heavily pre-treated metastatic breast cancer (MBC) ...
The 3-month extension follows a major amendment to the NDA for the intrathecal cyclodextrin-based therapy, which has shown a 71% reduction in mortality risk in clinical trials.
Natalizumab demonstrates sustained long-term safety and efficacy for treating relapsing-remitting multiple sclerosis through 15 years of follow-up.
Run two industry-standard scanners on the same container image and you will get two entirely different answers.
On April 23, 2026, Dr. Mehmet Oz, in his capacity as Administrator of the Centers for Medicare & Medicaid Services ("CMS"), ...
Pro-Trump lawyer Abelardo de la Espriella has taken the lead in Colombia’s presidential race after the first round of ...
Almost 300,000 NC voters voted via mail-in ballot in 2024 election. Here's what could change as a judge declines to block Trump's executive order.
A federal judge declined to block Trump’s mail-in voting order. Here's what it does, what hasn’t changed yet, and what to ...
It's part of a 13.3-million-acre area that stretches across nations.
Adults 60 and older reported $7.7 billion in losses to internet crime in 2025. Here are free steps to help protect your ...
CHICAGO, June 01, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results